je.st
news
Development Services: Solupath
2013-03-06 16:59:57| drugdiscoveryonline Home Page
Low solubility is a common but complex hurdle on the path to Phase I trials and commercialization. Typically, companies will have their compounds screened by a succession of separate vendors who are limited to their proprietary technology. This one-at-a-time approach is often costly and time consuming.
Tags: services
development
development services
services development
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||